Core Viewpoint - The company Sanxin Medical (300453.SZ) announced a share reduction plan involving multiple executives and shareholders, indicating a potential shift in ownership dynamics and investor sentiment [1][2] Group 1: Share Reduction Plans - The controlling shareholder and actual controller, Ms. Peng Jiulian, plans to reduce her holdings by up to 2,300,000 shares, representing 0.4404% of the total share capital [1] - The company's president, Mr. Mao Zhiping, intends to reduce his holdings by up to 743,412 shares, accounting for 0.1424% of the total share capital [1] - Director Mr. Le Zhenrong plans to reduce his holdings by up to 393,500 shares, which is 0.0753% of the total share capital [1] - Vice President and Secretary of the Board, Mr. Liu Ming, plans to reduce his holdings by up to 167,300 shares, representing 0.0320% of the total share capital [1] - Vice President Mr. Wang Ganying intends to reduce his holdings by up to 227,750 shares, accounting for 0.0436% of the total share capital [1] - Vice President Ms. Leng Lingli plans to reduce her holdings by up to 131,030 shares, which is 0.0251% of the total share capital [2] - Vice President Mr. Liu Bingrong intends to reduce his holdings by up to 130,650 shares, representing 0.0250% of the total share capital [2]
三鑫医疗(300453.SZ):实控人之一致行动人及部分董事、高管拟减持公司股份